Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Specificity of systems mediating transport of adenosine, 9-beta-d-arabinofuranosyl-2-fluoroadenine, and other purine nucleoside analogues in L1210 cells.

× No keyword cloud information.

6 in total

1. Protection against fludarabine neurotoxicity in leukemic mice by the nucleoside transport inhibitor nitrobenzylthioinosine.

Authors: A A Adjei; L Dagnino; M M Wong; A R Paterson
Journal: Cancer Chemother Pharmacol Date: 1992 Impact factor: 3.333

2. Modulation of the metabolism of beta-L-(-)-2',3'-dideoxy-3'-thiacytidine by thymidine, fludarabine, and nitrobenzylthioinosine.

Authors: J J Rahn; D M Kieller; D L Tyrrell; W P Gati
Journal: Antimicrob Agents Chemother Date: 1997-05 Impact factor: 5.191

Review 3. Membrane transport and the antineoplastic action of nucleoside analogues.

Authors: F M Sirotnak; J R Barrueco
Journal: Cancer Metastasis Rev Date: 1987 Impact factor: 9.264

4. The pentostatin plus cyclophosphamide nonmyeloablative regimen induces durable host T cell functional deficits and prevents murine marrow allograft rejection.

Authors: Jacopo Mariotti; Justin Taylor; Paul R Massey; Kaitlyn Ryan; Jason Foley; Nicole Buxhoeveden; Tania C Felizardo; Shoba Amarnath; Miriam E Mossoba; Daniel H Fowler
Journal: Biol Blood Marrow Transplant Date: 2010-12-03 Impact factor: 5.742

5. Inhibition of fludarabine metabolism by arabinosylcytosine during therapy.

Authors: A Kemena; V Gandhi; D S Shewach; M Keating; W Plunkett
Journal: Cancer Chemother Pharmacol Date: 1992 Impact factor: 3.333

Review 6. Fludarabine phosphate. A new anticancer drug with significant activity in patients with chronic lymphocytic leukemia and in patients with lymphoma.

Authors: G Rodriguez
Journal: Invest New Drugs Date: 1994 Impact factor: 3.850

6 in total